<DOC>
	<DOCNO>NCT02521363</DOCNO>
	<brief_summary>The purpose study test safety feasibility place remove small device contains anti-cancer drug breast tumor patient plan breast surgery without treatment prior patient plan receive standard preoperative chemotherapy prior breast surgery . This device may able predict type treatment work best individual 's breast cancer . With device , investigator hope able personalize treatment choice base individual 's type breast cancer .</brief_summary>
	<brief_title>Implantable Microdevice In Vivo Drug Sensitivity Testing Patients With Early Stage , HER2-Positive Triple Negative Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Triple Negative Breast Neoplasms</mesh_term>
	<criteria>Patients histologically confirm invasive breast cancer : Triple negative ( ER &lt; 10 % , PR &lt; 10 % , HER2 0/1+ 2+/FISH amplify ) Tumor size 2cm great ; N ; M0 Tumor size 1cm great ; N ; M0 ( Cohort 1 ) Tumor size 2cm great ; N ; M0 ( Cohort 2 ) Candidate curative breast cancer surgery ( Cohort 1 2 ) Candidate neoadjuvant chemotherapy standard care , anthracyclinebased regimen ( Cohort 2 prefer Cohort 1 ) Age &gt; 18 year age ECOG performance status â‰¤2 Serum urine pregnancy test negative within 2 week woman childbearing potential . Willing able provide inform consent Prior treatment include surgery , chemotherapy radiation therapy current primary breast cancer . Severe acute chronic medical psychiatric condition laboratory abnormality may increase risk associate study participation investigational device administration may interfere interpretation study result , judgment investigator , would make patient inappropriate entry</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Implantable Microdevice</keyword>
	<keyword>In Vivo Drug Sensitivity Testing</keyword>
	<keyword>HER2-Positive</keyword>
	<keyword>Triple Negative</keyword>
	<keyword>15-127</keyword>
</DOC>